Panel of human cell lines with human/mouse artificial chromosomes.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
22 02 2022
Historique:
received: 08 07 2021
accepted: 04 02 2022
entrez: 23 2 2022
pubmed: 24 2 2022
medline: 18 3 2022
Statut: epublish

Résumé

Human artificial chromosomes (HACs) and mouse artificial chromosomes (MACs) are non-integrating chromosomal gene delivery vectors for molecular biology research. Recently, microcell-mediated chromosome transfer (MMCT) of HACs/MACs has been achieved in various human cells that include human immortalised mesenchymal stem cells (hiMSCs) and human induced pluripotent stem cells (hiPSCs). However, the conventional strategy of gene introduction with HACs/MACs requires laborious and time-consuming stepwise isolation of clones for gene loading into HACs/MACs in donor cell lines (CHO and A9) and then transferring the HAC/MAC into cells via MMCT. To overcome these limitations and accelerate chromosome vector-based functional assays in human cells, we established various human cell lines (HEK293, HT1080, hiMSCs, and hiPSCs) with HACs/MACs that harbour a gene-loading site via MMCT. Model genes, such as tdTomato, TagBFP2, and ELuc, were introduced into these preprepared HAC/MAC-introduced cell lines via the Cre-loxP system or simultaneous insertion of multiple gene-loading vectors. The model genes on the HACs/MACs were stably expressed and the HACs/MACs were stably maintained in the cell lines. Thus, our strategy using this HAC/MAC-containing cell line panel has dramatically simplified and accelerated gene introduction via HACs/MACs.

Identifiants

pubmed: 35194085
doi: 10.1038/s41598-022-06814-3
pii: 10.1038/s41598-022-06814-3
pmc: PMC8863800
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3009

Informations de copyright

© 2022. The Author(s).

Références

Cancer Res. 2018 Nov 1;78(21):6282-6296
pubmed: 30166419
ACS Synth Biol. 2014 Dec 19;3(12):903-14
pubmed: 23654256
In Vitro Cell Dev Biol. 1986 Oct;22(10):615-20
pubmed: 3533893
Drug Metab Pharmacokinet. 2018 Feb;33(1):17-30
pubmed: 29398301
Mol Ther. 2009 Feb;17(2):309-17
pubmed: 19034264
Cell. 2019 Jul 25;178(3):624-639.e19
pubmed: 31348889
Sci Signal. 2016 Feb 23;9(416):ra22
pubmed: 26905427
Yonago Acta Med. 2016 Jun 29;59(2):174-82
pubmed: 27493490
Nat Biotechnol. 1998 May;16(5):431-9
pubmed: 9592390
Expert Opin Drug Deliv. 2014 Apr;11(4):517-35
pubmed: 24479793
Sci Rep. 2016 Feb 23;6:21419
pubmed: 26903378
Sci Transl Med. 2012 Jun 27;4(140):140ra89
pubmed: 22745439
J Gene Med. 2016 Oct;18(10):273-281
pubmed: 27591740
Oncotarget. 2018 Dec 7;9(96):36833-36835
pubmed: 30627324
Nucleic Acids Res. 2013 May 1;41(10):e107
pubmed: 23558748
Sci Rep. 2019 Nov 18;9(1):16954
pubmed: 31740706
Exp Cell Res. 2020 May 15;390(2):111914
pubmed: 32142854
Sci Rep. 2014 Jun 23;4:5400
pubmed: 24954249
Mol Ther Methods Clin Dev. 2014 Jan 08;1:1
pubmed: 26015941
Transgenic Res. 2015 Aug;24(4):717-27
pubmed: 26055730
Cytotechnology. 2018 Dec;70(6):1499-1508
pubmed: 30112660
Chromosome Res. 2015 Feb;23(1):111-33
pubmed: 25657031
PLoS One. 2016 Jun 07;11(6):e0157187
pubmed: 27271046
J Hum Genet. 2018 Feb;63(2):145-156
pubmed: 29180645
PLoS One. 2010 Aug 26;5(8):e12413
pubmed: 20865032
Hum Mol Genet. 2013 Feb 1;22(3):578-92
pubmed: 23125282
Mol Ther Nucleic Acids. 2015 Dec 15;4:e272
pubmed: 26670279
PLoS One. 2018 Mar 5;13(3):e0193642
pubmed: 29505588
Sci Rep. 2017 Oct 6;7(1):12739
pubmed: 28986519
BMC Biotechnol. 2015 Jun 19;15:58
pubmed: 26088202
BMC Biotechnol. 2010 May 06;10:37
pubmed: 20444293
Hum Mol Genet. 2001 May 15;10(11):1163-75
pubmed: 11371509
Chromosome Res. 2015 Feb;23(1):1-5
pubmed: 25682170
PLoS One. 2010 May 12;5(5):e10611
pubmed: 20485554
Sci Rep. 2017 Nov 9;7(1):15189
pubmed: 29123154
Sci Rep. 2014 Aug 27;4:6136
pubmed: 25159877
EMBO Mol Med. 2018 Feb;10(2):254-275
pubmed: 29242210
Biochem Biophys Res Commun. 2013 Dec 6;442(1-2):44-50
pubmed: 24216103
Drug Metab Rev. 2010 Feb;42(1):74-97
pubmed: 20067364
New Biol. 1990 May;2(5):441-9
pubmed: 2288914
Methods Mol Biol. 2017;1498:41-56
pubmed: 27709568
Mol Ther Nucleic Acids. 2020 Dec 19;23:629-639
pubmed: 33552683
Proc Natl Acad Sci U S A. 1977 Jan;74(1):319-23
pubmed: 264685
PLoS One. 2011 Feb 24;6(2):e17267
pubmed: 21390305
Stem Cells. 2005 Nov-Dec;23(10):1608-16
pubmed: 16141362
Biochem Biophys Res Commun. 2002 Jul 12;295(2):354-61
pubmed: 12150956
Proc Natl Acad Sci U S A. 2019 Feb 19;116(8):3072-3081
pubmed: 30718425
Gene Ther. 2011 Apr;18(4):384-93
pubmed: 21085194
PLoS One. 2014 Oct 10;9(10):e110404
pubmed: 25303219
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Cancer. 1974 Apr;33(4):1027-33
pubmed: 4132053
Sci Transl Med. 2011 Aug 17;3(96):96ra78
pubmed: 21849666

Auteurs

Narumi Uno (N)

Division of Genome and Cellular Functions, Department of Molecular and Cellular Biology, Faculty of Medicine, School of Life Science, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan. narumi@toyaku.ac.jp.
Chromosome Engineering Research Center, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan. narumi@toyaku.ac.jp.
Laboratory of Bioengineering, Faculty of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachiohji, Tokyo, 192-0392, Japan. narumi@toyaku.ac.jp.

Shuta Takata (S)

Division of Genome and Cellular Functions, Department of Molecular and Cellular Biology, Faculty of Medicine, School of Life Science, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan.

Shinya Komoto (S)

Division of Genome and Cellular Functions, Department of Molecular and Cellular Biology, Faculty of Medicine, School of Life Science, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan.

Hitomaru Miyamoto (H)

Division of Genome and Cellular Functions, Department of Molecular and Cellular Biology, Faculty of Medicine, School of Life Science, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan.

Yuji Nakayama (Y)

Division of Radioisotope Science, Research Initiative Center, Organization for Research Initiative and Promotion, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan.

Mitsuhiko Osaki (M)

Chromosome Engineering Research Center, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan.
Division of Experimental Pathology, Department of Biomedical Sciences, Faculty of Medicine, Tottori University, Yonago, Tottori, 683-8503, Japan.

Ryota Mayuzumi (R)

Laboratory of Bioengineering, Faculty of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachiohji, Tokyo, 192-0392, Japan.

Natsumi Miyazaki (N)

Laboratory of Bioengineering, Faculty of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachiohji, Tokyo, 192-0392, Japan.

Chiaki Hando (C)

Laboratory of Bioengineering, Faculty of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachiohji, Tokyo, 192-0392, Japan.

Satoshi Abe (S)

Chromosome Engineering Research Center, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan.

Tetsushi Sakuma (T)

Division of Integrated Sciences for Life, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima, 739-8526, Japan.

Takashi Yamamoto (T)

Division of Integrated Sciences for Life, Graduate School of Integrated Sciences for Life, Hiroshima University, Higashi-Hiroshima, Hiroshima, 739-8526, Japan.

Teruhiko Suzuki (T)

Stem Cell Project, Tokyo Metropolitan Institute of Medical Science, Kamikitazawa, Setagaya-ku, Tokyo, 156-8506, Japan.

Yoshihiro Nakajima (Y)

Health Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Takamatsu, Kagawa, 761-0395, Japan.

Mitsuo Oshimura (M)

Chromosome Engineering Research Center, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan.

Kazuma Tomizuka (K)

Laboratory of Bioengineering, Faculty of Life Sciences, Tokyo University of Pharmacy and Life Sciences, 1432-1 Horinouchi, Hachiohji, Tokyo, 192-0392, Japan.

Yasuhiro Kazuki (Y)

Division of Genome and Cellular Functions, Department of Molecular and Cellular Biology, Faculty of Medicine, School of Life Science, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan. kazuki@tottori-u.ac.jp.
Chromosome Engineering Research Center, Tottori University, 86 Nishi-cho, Yonago, Tottori, 683-8503, Japan. kazuki@tottori-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH